Remove Bioequivalency Remove Clinical Trials Remove Marketing Remove Pharmacy
article thumbnail

Biosimilars vs. Interchangeable Biological Products: FDA Fact Check

XTalks

As biologics have the reputation of being expensive due to their complex nature and production, biosimilars have the ability to improve market access to patients and payors who would otherwise be unable to afford these drugs. To date, the FDA has approved 29 biosimilars, 19 of which are currently being marketed.

article thumbnail

Cerelle vs Cerazette: Are they really the same?

Druggist

Can I ask the pharmacy to dispense Cerazette instead of Cerelle? Before December 2015, Cerazette was protected by a patent, which gave producers of this pill exclusive rights of supply of desogestrel in the UK and other markets. Can I ask the pharmacy to dispense Cerazette instead of Cerelle? . How can I get Cerazette pill?